# TheraCal LC Coronal Pulpotomy and MTA Coronal Pulpotomy in Mature Permanent Molars

> **NCT05733468** · PHASE4 · UNKNOWN · sponsor: **Postgraduate Institute of Dental Sciences Rohtak** · enrollment: 72 (actual)

## Conditions studied

- Irreversible Pulpitis
- Deep Caries

## Interventions

- **DRUG:** Theracal LC
- **DRUG:** MTA

## Key facts

- **NCT ID:** NCT05733468
- **Lead sponsor:** Postgraduate Institute of Dental Sciences Rohtak
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-01
- **Primary completion:** 2024-03-01
- **Final completion:** 2024-05-30
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2023-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05733468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05733468, "TheraCal LC Coronal Pulpotomy and MTA Coronal Pulpotomy in Mature Permanent Molars". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05733468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*